Clicky

Friday, November 20, 2026
All public companies · Official EDGAR

OBXObsidian Therapeutics, Inc.

Nasdaq · CIK 0002130606
Filer categoryNon-accelerated filer<br>Smaller reporting company<br>Emerging growth company
Entity typeoperating
SIC2834 Pharmaceutical Preparations
FY end1231
XBRL facts206

Identity from submissions API

NameObsidian Therapeutics, Inc.
CIK0002130606
TickersOBX
ExchangesNasdaq
Entity typeoperating
CategoryNon-accelerated filer<br>Smaller reporting company<br>Emerging growth company
SIC2834 Pharmaceutical Preparations
EIN421977778
LEI—
Fiscal year end1231
State of incorporation—
Phone(781) 806-6245
Website—
Investor website—
Owner org03 Life Sciences
Flags—
Description—
Insider transactions (issuer)1
Insider transactions (owner)0

Former names

  • Gazelle Parent, Inc. (2026-04-22T04:00:00.000Z → 2026-08-03T04:00:00.000Z)
Business address
1030 MASSACHUSETTS AVENUE
CAMBRIDGE
MA
02138
MA
Mailing address
1030 MASSACHUSETTS AVENUE
CAMBRIDGE
MA
02138
MA

EDGAR has no company-logo API. Website field is shown when the filer provided one.

Financialist coverage

SEC filings

44 filing rows loaded from submissions recent.

FiledFormDocumentItemsAccessionFile no.FilmActSizeXBRLiXBRL
2026-11-16 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0001172661-26-005078 005-95853 261555800 34 13169
2026-11-13 4 OWNERSHIP DOCUMENT 0001104659-26-127203 5712
2026-11-13 3 OWNERSHIP DOCUMENT 0001104659-26-127194 11167
2026-11-13 4 4 0001193125-26-460934 5676
2026-11-13 4 4 0001193125-26-460933 5500
2026-11-13 4/A 4/A 0001193125-26-460927 5966
2026-11-12 424B3 424B3 0001193125-26-458456 333-298642 261547194 33 1424679
2026-11-12 10-Q 10-Q 0001193125-26-458414 001-43430 261547104 34 12031253 1 1
2026-11-12 8-K 8-K 2.02,9.01 0001193125-26-458347 001-43430 261546931 34 215255 1 1
2026-10-05 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0001104659-26-113688 005-95853 261440261 34 16218
2026-09-09 EFFECT xslEFFECTX01/primary_doc.xml ,, 9999999995-26-002925 333-298642 261370095 33 1798
2026-08-28 S-1 S-1 0001193125-26-374729 333-298642 261341413 33 15188901 1 1
2026-08-14 8-K/A 8-K/A 9.01 0001193125-26-352388 001-43430 261282431 34 2516071 1 1
2026-08-14 10-Q 10-Q 0001193125-26-352381 001-43430 261282383 34 1399027 1 1
2026-08-11 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0001172661-26-003281 005-95853 261263077 34 13003
2026-08-10 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0001628098-26-000007 005-95853 261259140 34 76170
2026-08-10 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0001346824-26-000218 005-95853 261258796 34 19674
2026-08-10 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0001388325-26-000037 005-95853 261258763 34 7409
2026-08-05 4 4 0001193125-26-335113 5552
2026-08-05 4 4 0001193125-26-335083 5560
2026-08-05 4 4 0001193125-26-335082 5579
2026-08-05 4 4 0001193125-26-335078 5553
2026-08-05 4 4 0001193125-26-335055 5499
2026-08-05 4 4 0001193125-26-335045 5546
2026-08-03 3 3 0001193125-26-331005 18225
2026-08-03 3 3 0001193125-26-331002 22659
2026-08-03 3 3 0001193125-26-330998 17824
2026-08-03 3 3 0001193125-26-330988 20568
2026-08-03 3 3 0001193125-26-330982 25977
2026-08-03 3 3 0001193125-26-330979 21330
2026-08-03 3 3 0001193125-26-330977 23094
2026-08-03 3 3 0001193125-26-330973 19755
2026-08-03 S-8 S-8 0001193125-26-330881 333-297941 261234616 33 694577 1 1
2026-08-03 8-K 8-K 1.01,2.01,2.02,3.02,3.03,4.01,5.01,5.02,5.03,7.01,9.01 0001193125-26-330810 001-43430 261234319 34 5068664 1 1
2026-08-03 CERT OBX_8A_Cert_0002130606.pdf 0001354457-26-000748 001-43430 261231828 34 180866
2026-08-03 8-A12B/A 8-A12B/A 0001193125-26-329768 001-43430 261230964 34 14782
2026-08-03 8-A12B 8-A12B 0001193125-26-329642 001-43430 261230613 34 14242
2026-07-02 EFFECT xslEFFECTX01/primary_doc.xml ,, 9999999995-26-002188 333-295249 261153996 33 1718
2026-07-02 424B3 424B3 0001193125-26-294834 333-295249 261152563 33 8244112
2026-07-02 S-4/A S-4/A 0001193125-26-293383 333-295249 261147668 33 8354237
2026-06-30 S-4/A S-4/A NO. 3 0001193125-26-290449 333-295249 261140428 33 8568871
2026-06-24 S-4/A S-4/A NO. 2 0001193125-26-281076 333-295249 261116041 33 9808630 1 1
2026-06-02 S-4/A S-4/A 0001193125-26-253683 333-295249 261056902 33 9477718
2026-04-22 S-4 S-4 0001193125-26-170834 333-295249 26884765 33 8689562 1 1

Latest XBRL company facts

One latest value per concept from companyfacts (206 concepts). Full history stays in the JSON.

TaxonomyTagLabelUnitValueStartEndFYFPFormFiledAccn
dei EntityCommonStockSharesOutstanding Entity Common Stock, Shares Outstanding shares 61.77M 2026-11-09 2026 Q3 10-Q 2026-11-12 0001193125-26-458414
ffd NetFeeAmt NetFeeAmt USD 71,528.17 2026-08-28 S-1 2026-08-28 0001193125-26-374729
ffd TtlFeeAmt TtlFeeAmt USD 71,528.17 2026-08-28 S-1 2026-08-28 0001193125-26-374729
ffd TtlOfferingAmt TtlOfferingAmt USD 517.94M 2026-08-28 S-1 2026-08-28 0001193125-26-374729
ffd TtlOffsetAmt TtlOffsetAmt USD 0 2026-08-28 S-1 2026-08-28 0001193125-26-374729
ffd TtlPrevslyPdAmt TtlPrevslyPdAmt USD 0 2026-08-28 S-1 2026-08-28 0001193125-26-374729
us-gaap AccountsPayableCurrent Accounts Payable, Current USD 569,000 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458414
us-gaap AccretionAmortizationOfDiscountsAndPremiumsInvestments Accretion (Amortization) of Discounts and Premiums, Investments USD 901,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458414
us-gaap AccruedLiabilitiesCurrent Accrued Liabilities, Current USD 15.54M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458414
us-gaap AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment USD 9.51M 2025-12-31 S-1 2026-08-28 0001193125-26-374729
us-gaap AccumulatedDepreciationDepletionAndAmortizationReclassificationsFromPropertyPlantAndEquipment1 Accumulated Depreciation, Depletion and Amortization, Reclassifications from Property, Plant and Equipment USD 1.50M 2025-01-01 2025-12-31 S-1 2026-08-28 0001193125-26-374729
us-gaap AccumulatedOtherComprehensiveIncomeLossNetOfTax Accumulated Other Comprehensive Income (Loss), Net of Tax USD -1.20M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458414
us-gaap AdditionalPaidInCapital Additional Paid in Capital USD 41.72M 2026-06-30 S-1 2026-08-28 0001193125-26-374729
us-gaap AdditionalPaidInCapitalCommonStock Additional Paid in Capital, Common Stock USD 713.86M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458414
us-gaap AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue APIC, Share-based Payment Arrangement, Increase for Cost Recognition USD 2.26M 2026-07-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458414
us-gaap AllocatedShareBasedCompensationExpense Share-based Payment Arrangement, Expense USD 5.26M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458414
us-gaap AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount shares 6.93M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458414
us-gaap Assets Assets USD 340.74M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458414
us-gaap AssetsCurrent Assets, Current USD 224.54M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458414
us-gaap AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax USD 0 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458414
us-gaap AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax Debt Securities, Available-for-sale, Accumulated Gross Unrealized Loss, before Tax USD 1.20M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458414
us-gaap AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost Debt Securities, Available-for-Sale, Amortized Cost, Maturity, Allocated and Single Maturity Date, after Year One Through Five USD 0 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458414
us-gaap AvailableForSaleSecuritiesDebtMaturitiesRemainderOfFiscalYearAmortizedCostBasis Debt Securities, Available-for-Sale, Amortized Cost, Maturity, Allocated and Single Maturity Date, Remainder of Fiscal Year USD 148.70M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458414
us-gaap AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost Debt Securities, Available-for-Sale, Amortized Cost, Maturity, Allocated and Single Maturity Date, Year One USD 110.30M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458414
us-gaap CashAndCashEquivalentsAtCarryingValue Cash and Cash Equivalents, at Carrying Value USD 66.51M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458414
us-gaap CashCashEquivalentsAndShortTermInvestments Cash, Cash Equivalents, and Short-term Investments USD 324.40M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458414
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents USD 67.61M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458414
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations USD 18.99M 2026-06-30 S-1 2026-08-28 0001193125-26-374729
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect USD 26.20M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458414
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffectDisposalGroupIncludingDiscontinuedOperations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffectDisposalGroupIncludingDiscontinuedOperations USD -22.42M 2026-01-01 2026-06-30 S-1 2026-08-28 0001193125-26-374729
us-gaap ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1 Class of Warrant or Right, Exercise Price of Warrants or Rights USD/shares 561.33 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458414
us-gaap ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights Class of Warrant or Right, Number of Securities Called by Warrants or Rights shares 46,676 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458414
us-gaap CommitmentsAndContingencies Commitments and Contingencies USD 0 2026-06-30 2026 Q2 10-Q 2026-08-14 0001193125-26-352381
us-gaap CommonStockCapitalSharesReservedForFutureIssuance Common Stock, Capital Shares Reserved for Future Issuance shares 5.33M 2026-06-30 S-1 2026-08-28 0001193125-26-374729
us-gaap CommonStockParOrStatedValuePerShare Common Stock, Par or Stated Value Per Share USD/shares 0 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458414
us-gaap CommonStockSharesAuthorized Common Stock, Shares Authorized shares 500.00M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458414
us-gaap CommonStockSharesIssued Common Stock, Shares, Issued shares 61.77M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458414
us-gaap CommonStockSharesOutstanding Common Stock, Shares, Outstanding shares 61.77M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458414
us-gaap CommonStockValue Common Stock, Value, Issued USD 6,000 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458414
us-gaap CompensationAndBenefitsTrust Compensation and Benefits Trust USD 4.14M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458414
us-gaap ComprehensiveIncomeNetOfTax Comprehensive Income (Loss), Net of Tax, Attributable to Parent USD -97.38M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458414
us-gaap ConversionOfStockAmountConverted1 Conversion of Stock, Amount Converted USD 338.03M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458414
us-gaap ConvertiblePreferredStockSharesIssuedUponConversion Convertible Preferred Stock, Shares Issued upon Conversion shares 7.09M 2026-02-28 S-1 2026-08-28 0001193125-26-374729
us-gaap DebtSecuritiesAvailableForSaleAllowanceForCreditLoss Debt Securities, Available-for-sale, Allowance for Credit Loss USD 0 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458414
us-gaap DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestBeforeAllowanceForCreditLoss DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestBeforeAllowanceForCreditLoss USD 325.55M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458414
us-gaap DebtSecuritiesAvailableForSaleExcludingAccruedInterest DebtSecuritiesAvailableForSaleExcludingAccruedInterest USD 324.35M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458414
us-gaap DeferredIncomeTaxLiabilities Deferred Tax Liabilities, Gross USD 1.62M 2025-12-31 S-1 2026-08-28 0001193125-26-374729
us-gaap DeferredTaxAssetsGross Deferred Tax Assets, Gross USD 99.68M 2025-12-31 S-1 2026-08-28 0001193125-26-374729
us-gaap DeferredTaxAssetsInProcessResearchAndDevelopment Deferred Tax Assets, in Process Research and Development USD 23.25M 2025-12-31 S-1 2026-08-28 0001193125-26-374729
us-gaap DeferredTaxAssetsLiabilitiesNet Deferred Tax Assets, Net USD 0 2025-12-31 S-1 2026-08-28 0001193125-26-374729
us-gaap DeferredTaxAssetsNet Deferred Tax Assets, Net of Valuation Allowance USD 1.62M 2025-12-31 S-1 2026-08-28 0001193125-26-374729
us-gaap DeferredTaxAssetsOperatingLossCarryforwards Deferred Tax Assets, Operating Loss Carryforwards USD 49.89M 2025-12-31 S-1 2026-08-28 0001193125-26-374729
us-gaap DeferredTaxAssetsOperatingLossCarryforwardsForeign Deferred Tax Assets, Operating Loss Carryforwards, Foreign USD 186.50M 2025-12-31 S-1 2026-08-28 0001193125-26-374729
us-gaap DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal Deferred Tax Assets, Operating Loss Carryforwards, State and Local USD 171.00M 2025-12-31 S-1 2026-08-28 0001193125-26-374729
us-gaap DeferredTaxAssetsOther Deferred Tax Assets, Other USD 1.20M 2025-12-31 S-1 2026-08-28 0001193125-26-374729
us-gaap DeferredTaxAssetsTaxCreditCarryforwardsForeign Deferred Tax Assets, Tax Credit Carryforwards, Foreign USD 17.10M 2025-12-31 S-1 2026-08-28 0001193125-26-374729
us-gaap DeferredTaxAssetsTaxCreditCarryforwardsResearch Deferred Tax Assets, Tax Credit Carryforwards, Research USD 7.70M 2025-12-31 S-1 2026-08-28 0001193125-26-374729
us-gaap DeferredTaxAssetsValuationAllowance Deferred Tax Assets, Valuation Allowance USD 98.06M 2025-12-31 S-1 2026-08-28 0001193125-26-374729
us-gaap DefinedContributionPlanEmployerMatchingContributionPercentOfMatch Defined Contribution Plan, Employer Matching Contribution, Percent of Match pure 1 2020-01-31 2026 Q3 10-Q 2026-11-12 0001193125-26-458414
us-gaap DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent Defined Contribution Plan, Maximum Annual Contributions Per Employee, Percent pure 0.03 2020-01-31 2026 Q3 10-Q 2026-11-12 0001193125-26-458414
us-gaap Depreciation Depreciation USD 885,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458414
us-gaap EarningsPerShareBasic Earnings Per Share, Basic USD/shares -6.19 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458414
us-gaap EarningsPerShareDiluted Earnings Per Share, Diluted USD/shares -6.19 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458414
us-gaap EffectiveIncomeTaxRateContinuingOperations Effective Income Tax Rate Reconciliation, Percent pure 0 2025-01-01 2025-12-31 S-1 2026-08-28 0001193125-26-374729
us-gaap EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent pure 0.21 2025-01-01 2025-12-31 S-1 2026-08-28 0001193125-26-374729
us-gaap EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent pure -0.239 2025-01-01 2025-12-31 S-1 2026-08-28 0001193125-26-374729
us-gaap EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Percent pure -0.008 2025-01-01 2025-12-31 S-1 2026-08-28 0001193125-26-374729
us-gaap EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent pure -0.001 2025-01-01 2025-12-31 S-1 2026-08-28 0001193125-26-374729
us-gaap EffectiveIncomeTaxRateReconciliationTaxCreditsResearch Effective Income Tax Rate Reconciliation, Tax Credit, Research, Percent pure 0.038 2025-01-01 2025-12-31 S-1 2026-08-28 0001193125-26-374729
us-gaap EmployeeBenefitsAndShareBasedCompensation Employee Benefits and Share-based Compensation USD 3.01M 2026-01-01 2026-06-30 S-1 2026-08-28 0001193125-26-374729
us-gaap FairValueAdjustmentOfWarrants Fair Value Adjustment of Warrants USD -3,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458414
us-gaap FinanceLeaseLiabilityCurrent Finance Lease, Liability, Current USD 1,000 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458414
us-gaap GainLossOnDispositionOfAssets Gain (Loss) on Disposition of Property Plant Equipment, Excluding Oil and Gas Property and Timber Property USD 56,000 2026-01-01 2026-06-30 S-1 2026-08-28 0001193125-26-374729
us-gaap GainLossOnSaleOfPropertyPlantEquipment Gain (Loss) on Disposition of Property Plant Equipment USD -2,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458414
us-gaap GeneralAndAdministrativeExpense General and Administrative Expense USD 19.45M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458414
us-gaap GeneralInsuranceExpense General Insurance Expense USD 1.17M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458414
us-gaap ImpairmentOfLongLivedAssetsToBeDisposedOf Impairment of Long-Lived Assets to be Disposed of USD 0 2025-01-01 2025-12-31 S-1 2026-08-28 0001193125-26-374729
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest USD -96.15M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458414
us-gaap IncomeTaxExpenseBenefit Income Tax Expense (Benefit) USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458414
us-gaap IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount USD 24.06M 2025-01-01 2025-12-31 S-1 2026-08-28 0001193125-26-374729
us-gaap IncomeTaxReconciliationForeignIncomeTaxRateDifferential Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Amount USD 777,000 2025-01-01 2025-12-31 S-1 2026-08-28 0001193125-26-374729
us-gaap IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount USD -21.13M 2025-01-01 2025-12-31 S-1 2026-08-28 0001193125-26-374729
us-gaap IncomeTaxReconciliationStateAndLocalIncomeTaxes Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Amount USD 73,000 2025-01-01 2025-12-31 S-1 2026-08-28 0001193125-26-374729
us-gaap IncomeTaxReconciliationTaxCreditsResearch Effective Income Tax Rate Reconciliation, Tax Credit, Research, Amount USD -3.78M 2025-01-01 2025-12-31 S-1 2026-08-28 0001193125-26-374729
us-gaap IncreaseDecreaseInAccountsPayable Increase (Decrease) in Accounts Payable USD -2.94M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458414
us-gaap IncreaseDecreaseInAccruedLiabilities Increase (Decrease) in Accrued Liabilities USD 5.56M 2026-01-01 2026-06-30 S-1 2026-08-28 0001193125-26-374729
us-gaap IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities USD 3.19M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458414
us-gaap IncreaseDecreaseInOperatingCapital Increase (Decrease) in Operating Capital USD 0 2026-04-11 2026-06-30 2026 Q2 10-Q 2026-08-14 0001193125-26-352381
us-gaap IncreaseDecreaseInOtherNoncurrentLiabilities Increase (Decrease) in Other Noncurrent Liabilities USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458414
us-gaap IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets Increase (Decrease) in Prepaid Expense and Other Assets USD 7.64M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458414
us-gaap InterestReceivableCurrent Interest Receivable, Current USD 1.66M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458414
us-gaap InvestmentIncomeNet Investment Income, Net USD 3.18M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458414
us-gaap LaborAndRelatedExpense Labor and Related Expense USD 8.43M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458414
us-gaap LeaseCost Lease, Cost USD 3.30M 2025-01-01 2025-12-31 S-1 2026-08-28 0001193125-26-374729
us-gaap LesseeOperatingLeaseLiabilityPaymentsDue Lessee, Operating Lease, Liability, to be Paid USD 4.56M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458414
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths Lessee, Operating Lease, Liability, to be Paid, Year One USD 1.63M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458414
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearFour Lessee, Operating Lease, Liability, to be Paid, Year Four USD 643,000 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458414
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearThree Lessee, Operating Lease, Liability, to be Paid, Year Three USD 598,000 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458414
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearTwo Lessee, Operating Lease, Liability, to be Paid, Year Two USD 673,000 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458414
us-gaap LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year USD 746,000 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458414
us-gaap LesseeOperatingLeaseLiabilityUndiscountedExcessAmount Lessee, Operating Lease, Liability, Undiscounted Excess Amount USD 509,000 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458414
us-gaap Liabilities Liabilities USD 20.16M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458414
us-gaap LiabilitiesAndStockholdersEquity Liabilities and Equity USD 340.74M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458414
us-gaap LiabilitiesCurrent Liabilities, Current USD 18.26M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458414
us-gaap MarketableSecurities Marketable Securities USD 34.40M 2026-06-30 S-1 2026-08-28 0001193125-26-374729
us-gaap MarketableSecuritiesCurrent Marketable Securities, Current USD 148.40M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458414
us-gaap MarketableSecuritiesNoncurrent Marketable Securities, Noncurrent USD 109.45M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458414
us-gaap NetCashProvidedByUsedInFinancingActivities Net Cash Provided by (Used in) Financing Activities USD 331.37M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458414
us-gaap NetCashProvidedByUsedInInvestingActivities Net Cash Provided by (Used in) Investing Activities USD -221.17M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458414
us-gaap NetCashProvidedByUsedInOperatingActivities Net Cash Provided by (Used in) Operating Activities USD -84.00M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458414
us-gaap NetIncomeLoss Net Income (Loss) Attributable to Parent USD -96.15M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458414
us-gaap NoncashOrPartNoncashAcquisitionValueOfLiabilitiesAssumed1 Noncash or Part Noncash Acquisition, Value of Liabilities Assumed USD 389,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458414
us-gaap NonoperatingIncomeExpense Nonoperating Income (Expense) USD 3.18M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458414
us-gaap NumberOfReportableSegments Number of Reportable Segments Segment 1 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458414
us-gaap OperatingExpenses Operating Expenses USD 99.33M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458414
us-gaap OperatingIncomeLoss Operating Income (Loss) USD -99.33M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458414
us-gaap OperatingLeaseCost Operating Lease, Cost USD 2.20M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458414
us-gaap OperatingLeaseLiability Operating Lease, Liability USD 4.05M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458414
us-gaap OperatingLeaseLiabilityCurrent Operating Lease, Liability, Current USD 2.15M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458414
us-gaap OperatingLeaseLiabilityNoncurrent Operating Lease, Liability, Noncurrent USD 1.90M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458414
us-gaap OperatingLeasePayments Operating Lease, Payments USD 2.20M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458414
us-gaap OperatingLeaseRightOfUseAsset Operating Lease, Right-of-Use Asset USD 4.09M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458414
us-gaap OperatingLeaseWeightedAverageDiscountRatePercent Operating Lease, Weighted Average Discount Rate, Percent pure 0.079 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458414
us-gaap OtherAssetsNoncurrent Other Assets, Noncurrent USD 0 2026-06-30 2026 Q2 10-Q 2026-08-14 0001193125-26-352381
us-gaap OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent Other Comprehensive Income (Loss), before Tax, Portion Attributable to Parent USD 0 2026-04-11 2026-06-30 2026 Q2 10-Q 2026-08-14 0001193125-26-352381
us-gaap OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent USD -1.22M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458414
us-gaap OtherComprehensiveIncomeLossTaxPortionAttributableToParent1 Other Comprehensive Income (Loss), Tax, Portion Attributable to Parent USD 0 2026-04-11 2026-06-30 2026 Q2 10-Q 2026-08-14 0001193125-26-352381
us-gaap OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, after Tax USD -1.22M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458414
us-gaap OtherGeneralAndAdministrativeExpense Other General and Administrative Expense USD 16.39M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458414
us-gaap OtherLiabilitiesCurrent Other Liabilities, Current USD 1.59M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458414
us-gaap OtherLiabilitiesNoncurrent Other Liabilities, Noncurrent USD 0 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458414
us-gaap OtherNoncashIncomeExpense Other Noncash Income (Expense) USD 106,000 2026-01-01 2026-06-30 S-1 2026-08-28 0001193125-26-374729
us-gaap OtherOperatingIncome Other Operating Income USD 407,000 2026-01-01 2026-06-30 S-1 2026-08-28 0001193125-26-374729
us-gaap OtherPrepaidExpenseCurrent Other Prepaid Expense, Current USD 922,000 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458414
us-gaap PaymentsOfStockIssuanceCosts Payments of Stock Issuance Costs USD 19.46M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458414
us-gaap PaymentsToAcquireBusinessesNetOfCashAcquired Payments to Acquire Businesses, Net of Cash Acquired USD 3.14M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458414
us-gaap PaymentsToAcquireMarketableSecurities Payments to Acquire Marketable Securities USD 258.59M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458414
us-gaap PaymentsToAcquirePropertyPlantAndEquipment Payments to Acquire Property, Plant, and Equipment USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458414
us-gaap PreferredStockConvertibleConversionPrice PreferredStockConvertibleConversionPrice USD/shares 1.129 2026-02-28 S-1 2026-08-28 0001193125-26-374729
us-gaap PreferredStockConvertibleSharesIssuable PreferredStockConvertibleSharesIssuable shares 207.95M 2026-06-30 S-1 2026-08-28 0001193125-26-374729
us-gaap PreferredStockLiquidationPreferenceValue Preferred Stock, Liquidation Preference, Value USD 329.00M 2026-06-30 S-1 2026-08-28 0001193125-26-374729
us-gaap PreferredStockParOrStatedValuePerShare Preferred Stock, Par or Stated Value Per Share USD/shares 0 2026-07-31 2026 Q3 10-Q 2026-11-12 0001193125-26-458414
us-gaap PreferredStockSharesAuthorized Preferred Stock, Shares Authorized shares 10.00M 2026-07-31 2026 Q3 10-Q 2026-11-12 0001193125-26-458414
us-gaap PreferredStockSharesOutstanding Preferred Stock, Shares Outstanding shares 207.95M 2026-06-30 S-1 2026-08-28 0001193125-26-374729
us-gaap PrepaidExpenseAndOtherAssetsCurrent Prepaid Expense and Other Assets, Current USD 9.63M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458414
us-gaap PrepaidExpenseNoncurrent Prepaid Expense, Noncurrent USD 606,000 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458414
us-gaap PrepaidInsurance Prepaid Insurance USD 873,000 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458414
us-gaap ProceedsFromIssuanceOfCommonStock Proceeds from Issuance of Common Stock USD 350.00M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458414
us-gaap ProceedsFromIssuanceOfPreferredStockAndPreferenceStock Proceeds from Issuance of Preferred Stock and Preference Stock USD 0 2025-01-01 2025-12-31 S-1 2026-08-28 0001193125-26-374729
us-gaap ProceedsFromSaleAndMaturityOfMarketableSecurities Proceeds from Sale and Maturity of Marketable Securities USD 40.50M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458414
us-gaap ProceedsFromSaleOfPropertyPlantAndEquipment Proceeds from Sale of Property, Plant, and Equipment USD 63,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458414
us-gaap ProceedsFromStockOptionsExercised Proceeds from Stock Options Exercised USD 843,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458414
us-gaap ProfessionalAndContractServicesExpense Professional and Contract Services Expense USD 6.78M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458414
us-gaap ProfitLoss Net Income (Loss), Including Portion Attributable to Noncontrolling Interest USD 96.15M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458414
us-gaap PropertyPlantAndEquipmentGross Property, Plant and Equipment, Gross USD 11.42M 2025-12-31 S-1 2026-08-28 0001193125-26-374729
us-gaap PropertyPlantAndEquipmentNet Property, Plant and Equipment, Net USD 961,000 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458414
us-gaap ReceivableFromShareholdersOrAffiliatesForIssuanceOfCapitalStock Receivable from Shareholders or Affiliates for Issuance of Capital Stock USD 0 2026-06-30 2026 Q2 10-Q 2026-08-14 0001193125-26-352381
us-gaap ResearchAndDevelopmentExpense Research and Development Expense USD 64.83M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458414
us-gaap ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost Research and Development Expense (Excluding Acquired in Process Cost) USD 375,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458414
us-gaap ResearchAndDevelopmentExpenseSoftwareExcludingAcquiredInProcessCost Research and Development Expense, Software (Excluding Acquired in Process Cost) USD 62.63M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458414
us-gaap RestrictedCashNoncurrent Restricted Cash, Noncurrent USD 1.10M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458414
us-gaap RetainedEarningsAccumulatedDeficit Retained Earnings (Accumulated Deficit) USD -392.09M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458414
us-gaap Revenues Revenues USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458414
us-gaap ShareBasedCompensation Share-based Payment Arrangement, Noncash Expense USD 5.26M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458414
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Aggregate Intrinsic Value, Outstanding USD 2.10M 2026-06-30 S-1 2026-08-28 0001193125-26-374729
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number shares 14.17M 2026-06-30 S-1 2026-08-28 0001193125-26-374729
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value USD/shares 0.78 2026-06-30 S-1 2026-08-28 0001193125-26-374729
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate pure 0 2026-01-01 2026-06-30 S-1 2026-08-28 0001193125-26-374729
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate pure 1.063 2025-01-01 2025-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458414
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate pure 0.043 2025-01-01 2025-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458414
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized shares 48.75M 2026-06-30 S-1 2026-08-28 0001193125-26-374729
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1 Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value USD 25.86M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458414
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number shares 21.47M 2026-06-30 S-1 2026-08-28 0001193125-26-374729
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price USD/shares 9.35 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458414
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value USD 300,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458414
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period shares 579,313 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458414
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period shares 337,611 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458414
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross shares 2.70M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458414
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested, Number of Shares shares 3.71M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458414
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value USD 42.12M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458414
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number shares 6.89M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458414
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price USD/shares 7.61 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458414
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Number shares 3.17M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458414
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price USD/shares 5.58 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458414
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price USD/shares 5.24 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458414
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Expirations in Period, Weighted Average Exercise Price USD/shares 5.55 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458414
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price USD/shares 5.64 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458414
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price USD/shares 10.74 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458414
us-gaap StockholdersEquity Stockholders' Equity Attributable to Parent USD 320.58M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458414
us-gaap StockIssuedDuringPeriodSharesNewIssues Stock Issued During Period, Shares, New Issues shares 1,000 2026-04-11 2026-06-30 2026 Q2 10-Q 2026-08-14 0001193125-26-352381
us-gaap StockIssuedDuringPeriodSharesStockOptionsExercised Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period shares 160,586 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458414
us-gaap StockIssuedDuringPeriodValueAcquisitions Stock Issued During Period, Value, Acquisitions USD 330.03M 2026-07-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458414
us-gaap StockIssuedDuringPeriodValueConversionOfConvertibleSecurities Stock Issued During Period, Value, Conversion of Convertible Securities USD 8.00M 2026-01-01 2026-03-31 2026 Q3 10-Q 2026-11-12 0001193125-26-458414
us-gaap StockIssuedDuringPeriodValueNewIssues Stock Issued During Period, Value, New Issues USD 330.53M 2026-07-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458414
us-gaap StockIssuedDuringPeriodValuePurchaseOfAssets Stock Issued During Period, Value, Purchase of Assets USD 9.33M 2026-07-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458414
us-gaap StockIssuedDuringPeriodValueStockOptionsExercised Stock Issued During Period, Value, Stock Options Exercised USD 796,000 2026-04-01 2026-06-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458414
us-gaap TemporaryEquityCarryingAmountAttributableToParent Temporary Equity, Carrying Amount, Attributable to Parent USD 0 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458414
us-gaap TemporaryEquityLiquidationPreference Temporary Equity, Liquidation Preference USD 337.00M 2025-12-31 2026 Q3 10-Q 2026-11-12 0001193125-26-458414
us-gaap TemporaryEquitySharesAuthorized Temporary Equity, Shares Authorized shares 215.06M 2025-12-31 2026 Q3 10-Q 2026-11-12 0001193125-26-458414
us-gaap TemporaryEquitySharesIssued Temporary Equity, Shares Issued shares 0 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458414
us-gaap TemporaryEquitySharesOutstanding Temporary Equity, Shares Outstanding shares 0 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458414
us-gaap UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued USD 0 2025-12-31 S-1 2026-08-28 0001193125-26-374729
us-gaap ValuationAllowanceDeferredTaxAssetChangeInAmount Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount USD 30.47M 2025-01-01 2025-12-31 S-1 2026-08-28 0001193125-26-374729
us-gaap VariableLeaseCost Variable Lease, Cost USD 541,000 2025-01-01 2025-12-31 S-1 2026-08-28 0001193125-26-374729
us-gaap WeightedAverageNumberOfDilutedSharesOutstanding Weighted Average Number of Shares Outstanding, Diluted shares 15.54M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458414
us-gaap WeightedAverageNumberOfSharesOutstandingBasic Weighted Average Number of Shares Outstanding, Basic shares 15.54M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458414

Financialist News Desk

Our desk turns official SEC filings into news. Each story is checked against the original filing. About us → · Editorial standards →